ReviewProtoplasma2025
Antidiabetic activity of polyherbal formulations: a comprehensive review.
Review in Protoplasma, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Combined Supplementation With Trigonella foenum-graecum and Nigella sativa Seed Powders Improves Glycemic Control, Dyslipidemia, and Organ Function in Alloxan-Induced Diabetic Rats.Journal of food science · 2026Article
- Research Progress on Polyphenols and Polysaccharides from Marine Seaweeds: Promising Diabetes Management Natural Products.Marine drugs · 2026Review
- Chemical Diversity and Biomedical Relevance of Oxalis corniculata L.: A Review of Nutritional and Pharmacological Aspects.Chemistry & biodiversity · 2026Review
- Investigation of the antidiabetic efficacy of Diabepat Kadha in type 2 diabetic Sprague-Dawley rats: modulation of GLUT4 expression as a molecular target.Journal of molecular histology · 2025Article
- Emerging Role ofMini reviews in medicinal chemistry · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Diabetes mellitus is a chronic condition marked by high blood glucose levels, resulting from either insufficient insulin production or poor insulin function. While conventional treatments have progressed, there is growing interest in alternative therapies, especially polyherbal formulations, due to their natural origin, cost-effectiveness, and fewer side effects. This review uniquely explores the antidiabetic potential of polyherbal formulations derived from various plants, focusing on their synergistic effects, where combinations of plant species work together to enhance therapeutic, outcomes. It discusses common plants used, types of extracts, plant parts, and dosing regimens in experimental studies. Both in vitro and in vivo models are examined to assess the effectiveness of these formulations in managing diabetes. The mechanisms behind their antidiabetic action-such as boosting insulin secretion, improving insulin sensitivity, regulating glucose metabolism, and reducing oxidative stress and inflammation-are highlighted. Overall, polyherbal formulations offer significant promise for integrating into diabetes management and reducing complications when used alongside conventional therapies. This review underscores the novelty of using polyherbal combinations to enhance diabetes treatment, offering a holistic and cost-effective approach to management. In conclusion, further research into these formulations could lead to more accessible and personalized therapeutic options for diabetes patients worldwide.
Indexed as
Identifiers
40178615What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.